Moving Osimertinib to First-Line: The Right “Strategy” in the Chessboard of Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer?

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2018.03.92
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

The Role of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

Dicle Medical Journal / Dicle Tip Dergisi
2015English

Somatic Mutations of the Epidermal Growth Factor Receptor and Non-Small-Cell Lung Cancer

Journal of Medical Genetics
Genetics
2006English

SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma

Oncologist
Cancer ResearchMedicineOncology
2018English

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

Yearbook of Pulmonary Disease
2006English

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2012English

Epidermal Growth Factor Receptor Status and Notch Inhibition in Non-Small Cell Lung Cancer Cells

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2015English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy